ACP
CASC

Acuta Capital Partners’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Acuta Capital Partners’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-111,667
Closed -$2.51M – 72
2015
Q2 		$2.51M Buy
+111,667
New +$2.51M 1.55% 24